FDA label f1ec390a-974d-4f1e-bf6b-379908630505

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
2806c460-33bb-4609-92f9-5edc0d66db65
SPL ID
f1ec390a-974d-4f1e-bf6b-379908630505
Version
2
Effective date
2020-10-13
Source export date
2026-11-06
Source partition
3
Source file
https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/97001096994db9ca8cee114e6c3bb5298d3c573158ffc1ab8692d82e76a3eb40/drug-label-0003-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 06:57:14

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS BodyAnew Rejuveo: If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to BodyAnew Rejuveo™ or any of its ingredients exists. BodyAnew Purity: If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to BodyAnew Purity™ or any of its ingredients exists. BodyAnew Fatigue: If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. For occasional use only. Not a substitute for sleep. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to BodyAnew Fatigue™ or any of its ingredients exists.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.